Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
The platform combines internally developed technologies, strategic partnerships, and external AI capabilities
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
We are building an AI-native operating system for pharma sales and distribution
The move targets long-standing bottlenecks in MSC science, including cell-to-cell variability, immunocompatibility concerns, and inefficient manufacturing workflows
Expands manufacturing push & locks in major growth deals
Initiative aims to strengthen South-South collaboration and capacity building in biomedical research
The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy
The company highlights role of integrated genomics and multi-omics research at the Illumina Multiomics Summit India 2026 held in New Delhi and Bengaluru
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
Subscribe To Our Newsletter & Stay Updated
